Amneal Pharmaceuticals (Germany) Performance
| 2DT Stock | EUR 8.25 0.50 6.45% |
Amneal Pharmaceuticals has a performance score of 6 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.53, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Amneal Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Amneal Pharmaceuticals is likely to outperform the market. Amneal Pharmaceuticals right now shows a risk of 2.21%. Please confirm Amneal Pharmaceuticals downside deviation, information ratio, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if Amneal Pharmaceuticals will be following its price patterns.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Amneal Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Amneal Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in March 2025. ...more
| Begin Period Cash Flow | 347.1 M | |
| Total Cashflows From Investing Activities | -194.2 M |
Amneal |
Amneal Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 750.00 in Amneal Pharmaceuticals on November 6, 2024 and sell it today you would earn a total of 75.00 from holding Amneal Pharmaceuticals or generate 10.0% return on investment over 90 days. Amneal Pharmaceuticals is currently producing 0.1883% returns and takes up 2.2061% volatility of returns over 90 trading days. Put another way, 19% of traded stocks are less volatile than Amneal, and 97% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Amneal Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Amneal Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Amneal Pharmaceuticals, and traders can use it to determine the average amount a Amneal Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0854
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 2DT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.21 actual daily | 19 81% of assets are more volatile |
Expected Return
| 0.19 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average Amneal Pharmaceuticals is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Amneal Pharmaceuticals by adding it to a well-diversified portfolio.
Amneal Pharmaceuticals Fundamentals Growth
Amneal Stock prices reflect investors' perceptions of the future prospects and financial health of Amneal Pharmaceuticals, and Amneal Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Amneal Stock performance.
| Return On Equity | -0.88 | |||
| Return On Asset | 0.0257 | |||
| Profit Margin | (0.06) % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 2.95 B | |||
| Shares Outstanding | 151.48 M | |||
| Price To Earning | 8.70 X | |||
| Price To Book | 1.17 X | |||
| Price To Sales | 0.29 X | |||
| Revenue | 2.09 B | |||
| EBITDA | 401.1 M | |||
| Cash And Equivalents | 452.1 M | |||
| Cash Per Share | 3.04 X | |||
| Total Debt | 2.72 B | |||
| Debt To Equity | 7.78 % | |||
| Book Value Per Share | 1.96 X | |||
| Cash Flow From Operations | 241.82 M | |||
| Earnings Per Share | (0.73) X | |||
| Total Asset | 3.94 B | |||
About Amneal Pharmaceuticals Performance
By analyzing Amneal Pharmaceuticals' fundamental ratios, stakeholders can gain valuable insights into Amneal Pharmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Amneal Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Amneal Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. Amneal Pharmaceuticals, Inc. was founded in 2002 and is based in Bridgewater, New Jersey. AMNEAL PHMCTCLS operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 6000 people.Things to note about Amneal Pharmaceuticals performance evaluation
Checking the ongoing alerts about Amneal Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Amneal Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Amneal Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| About 68.0% of the company shares are owned by institutions such as pension funds |
- Analyzing Amneal Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Amneal Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Amneal Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Amneal Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Amneal Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Amneal Pharmaceuticals' stock. These opinions can provide insight into Amneal Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Amneal Stock analysis
When running Amneal Pharmaceuticals' price analysis, check to measure Amneal Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals is operating at the current time. Most of Amneal Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals' price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |